In8Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.10

-0.08 (-6.78%)

As of Aug 14, 10:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +3,589.1% upside

Low Target $25.27

Average Target $40.58

High Target $56.74

Current Price $1.10

Current
$1.10

Target
$40.58

$25.27 $40.58 avg $56.74

Scenario Analysis

Bear Case

$25.27

2,197.3%

Low target

Base Case

$40.58

+3,589.1%

Avg target

Bull Case

$56.74

+5,058.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.73

-59.7% from high

52-Week Low

$0.90

+22.2% from low

Target vs 52W High

$40.58

+1,386.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%